Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016053 (
fibromyalgia
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Standard radioimmunoassay (RIA) was employed to quantify basal serum growth hormone (GH),
insulin-like growth factor-I
(IGF-1), and insulin levels in 32 normoglycemic patients with clinically active
fibromyalgia
and in 29 normoglycemic control subjects. The GH concentration was significantly higher (P < 0.001) in female
fibromyalgia
patients than age-matched, normal female subjects. In contrast, basal serum IGF-1 concentrations did not differ between these groups. A scatter plot generated from two-stage, least-squares analysis showed that serum GH lacked correlation with the serum IGF-1 concentrations of normal female subjects (P = 0.73) and female
fibromyalgia
patients (P = 0.19). In addition to the results from serum GH and IGF-1 RIA, we also found significantly higher fasting serum insulin levels (P = 0.03) in male
fibromyalgia
patients and a trend toward elevated fasting serum insulin levels in the female
fibromyalgia
population ( P = 0.07), with the mean fasting level in the male
fibromyalgia
group (35.7 microU/ml(-1)) exceeding the upper limit of normal serum insulin levels (i.e., 27 microU/ml(-1)). Based on these results, basal serum GH and fasting serum insulin levels appear to be valuable surrogate markers in clinically active, normoglycemic
fibromyalgia
patients.
...
PMID:Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. 1575 59